Sotera Health, Warburg Pincus, and GTCR in $381.75 Million Secondary Stock Offering

Cleary Gottlieb represented Sotera Health Company (Sotera Health) and two of its principal shareholders, Warburg Pincus and GTCR, in its $381.75 million secondary public offering of 25 million shares of common stock.

The offering priced on March 4, 2026, and is expected to close on March 6, 2026. All of the shares of common stock offered were sold by the selling shareholders. Sotera Health did not sell any shares and did not receive any proceeds from the offering.

Wells Fargo Securities LLC acted as underwriter for the offering.

Sotera Health is a leading global provider of mission-critical end-to-end sterilization solutions, lab testing, and advisory services for the healthcare industry.

The Cleary capital markets team included partner Lillian Tsu, associates Natalia Rezai and Aditi Thakur, and law clerk Ville Latola, with assistance from counsel David Parish. Partner Matthew Brigham and associate Adam Girts advised on U.S. tax matters.